High school science misses a lot of the science researchers actually work with. For example, you learn that there are three states of matter—solid, liquid, and gas—but in advanced physics, things get ...

In a city that prides itself on moving fast, nothing’s slower — or suddenly trendier — than waiting on line. These days, it seems that New Yorkers will stand around and wait for just about anything — ...

To learn more about these steps, continue reading. To get started, open the Excel spreadsheet and select cells. You can choose one or multiple cells at a time. However, there is only one catch. All ...

The contract, which will award nearly $2 billion to construction firms, funds crucial aspects of the latest phase of the long-awaited subway expansion into East Harlem. By Taylor Robinson Transit ...

LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for ...

New York City is one step closer to getting its first light rail. But it's still going to be awhile. Gov. Kathy Hochul on Friday announced that the engineering and design phase of the previously ...

The Interborough Express, a light-rail line that would directly connect Queens and Brooklyn, took a major step toward becoming a reality Friday. The project, also known as the IBX, has officially ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

April 10 (Reuters) - The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant ...